056090 — CG MedTech Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual cashflow statement for CG MedTech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-5,215	-18,808	1,306	-125	6,508
Depreciation
Amortisation
Non-Cash Items	4,818	20,391	-4,863	-2,036	-1,895
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital	-481	-9,184	-756	1,980	-4,263
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,285	-5,400	-2,460	1,511	2,613
Capital Expenditures	-862	-820	-1,590	-774	-11,479
Purchase of Fixed Assets
Other Investing Cash Flow Items	-3,789	-51,436	56,615	-8,176	-3,823
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-4,651	-52,255	55,025	-8,950	-15,302
Financing Cash Flow Items	—	5,300	-4,039	-52.1	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	10,421	67,886	-62,558	21,377	-3,735
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7,245	10,163	-9,851	14,290	-16,491